Intelligo

Private limited company · Lillestrøm

PROVECTUS PHARMA NORDIC AS

Being wound upRetail sale of other food (47.270)

Founded
11 Oct 2021
Business address
Slogumveien 99, 2015 Leirsund

The website has not been read for a card yet.

The life line 2021–2026

Operating revenue per year, with recorded events above. As a table

Operating revenue 2025: NOK 10.8m.

  1. Oppløsning§ 14
  2. Founded§ 16

Sources: the Register of Company Accounts (company accounts), fetched 15 Nov 2026; the Brønnøysund Register Centre. Each event has the colour of the section it is in.

In brief

Being wound up – after notification to the Register of Business Enterprises on 3 Sep 2026. Claims and objections go to the company within six weeks of 3 Sep 2026. See the announcement

PROVECTUS PHARMA NORDIC AS is being wound up voluntarily. The latest annual accounts are for 2025 and showed NOK 10.8m in operating revenue and a net profit of NOK −2.0m; equity was positive.

Put together by Intelligo from the sections below; each figure stands with its source where it belongs.

Overview

§ 01 Latest changes

4 changes, latest 4 Sep 2026

  • Winding-up decided 3 Sep 2026
  • Kreditorvarsel
  • Annual accounts filed 2024 → 2025
  • Forretningsadresse

Source: the Brønnøysund Register Centre and Intelligo's own observations, fetched 15 Nov 2026 · All events →

Overview

§ 02 Worth knowing

1 point

  • NoteBeing wound up since 3 Sep 2026

Assumed: derived by Intelligo by fixed rules, not a credit rating. How we calculate

Overview

§ 03 Key figures

Revenue NOK 10.8m in 2025

Revenue

NOK 10.8m

−46.4% from 2024

20232025

Operating profit

NOK −2.2m

−664.6% from 2024

20232025

Net profit

NOK −2.0m

−921.3% from 2024

20232025

Equity

NOK 110k

−94.9% from 2024

20232025

Source: the Register of Company Accounts, read 15 Nov 2026 · The full accounts →

Finances

§ 04 Where the money comes from and goes

Financial year 2025

Of every krone of operating revenue in 2025:

  • Wages and social costs 5%
  • Depreciation 0%
  • Other operating costs 21%
  • Not specified in the source 93%

Costs exceeded revenue: the operating result was NOK −2.2m.

Source: the Register of Company Accounts via areg.no, read 15 Nov 2026

Finances

§ 05 Financial health

Equity ratio 1.9%

RevenueNOK 10.8m Operating margin−20.1% Equity ratio1.9% Revenue growth−46.4%
  • PROVECTUS PHARMA NORDIC AS, 2025
  • Industry median, assumed: NOK 3.4m · 2.5% · 27.8% · +10.0%

Equity NOK 110k2% of the assets (NOK 5.7m)

Source: the Register of Company Accounts, read 15 Nov 2026. The median is derived by Intelligo from 462 companies in 47.270 Retail sale of other food, not stated by the source.

Finances

§ 06 Accounts

5 years, latest 2025

NOK 1,0002023–25202520242023
Operating revenue10,83320,20123,645
Operating profit−2,179386603
Profit before tax−2,042256500
Net profit−2,042249234
Total assets5,7239,1548,639
Equity1102,1521,903
Liabilities5,6137,0036,736

Source: the Register of Company Accounts, read 15 Nov 2026 · All 5 years →

Management and ownership

§ 07 Officers

5 officers now

The board: 3 members

Source: the Brønnøysund Register Centre, read 22 Oct 2026 · All 5 roles, former ones too →

Management and ownership

§ 08 Signature, procuration and authorisations

Styrets medlemmer hver for seg. Styrets leder alene.

May sign for the company:

Styrets medlemmer hver for seg. Styrets leder alene.

Procuration: none registered.

The signature is word for word from the register. Source: the Register of Business Enterprises, read 15 Nov 2026

Management and ownership

§ 09 Owners

1 shareholder · largest 100.0%

OwnerShare
PROVECTUS PHARMA INTERNATIONAL AS
100.0%

Source: the Tax Administration's Register of Shareholders as of 31 December 2025, read 31 Jul 2026 · All 1 owners →

Management and ownership

§ 10 Group

None registered

Not a group.No subsidiaries in the shareholder register, and no group accounts. Checked 15 Nov 2026.

Management and ownership

§ 11 Portfolio

None registered

No holdings registered.The shareholder register has no shares held by the company. Checked 15 Nov 2026.

Management and ownership

§ 12 Network

20 connections

  • Person
  • Company

3 people link PROVECTUS PHARMA NORDIC AS to 10 other companies: Ronny Licina Steng 7, Jarle André Nummestad 4 and Eddy Licina Steng 4.

Source: the Brønnøysund Register Centre, read 22 Oct 2026 · Explore the network →

Events and registers

§ 13 Events

11 since 2021

Events per year

20212026

  • Notices4
  • Owners in and out4
  • Register changes3

Since 2021: 4 announcements, 3 register changes and 1 new and 3 former owners. Most happened in 2022 and 2026.

Source: the announcements of the Brønnøysund Register Centre, the Tax Administration's Register of Shareholders, Doffin, TED and NAV, read 15 Nov 2026. Register changes are Intelligo's own observations. · All 11 events →

Events and registers

§ 14 Notices

4, latest 3 Sep 2026

  • Oppløsning
  • Forretningsadresse
  • Godkjente årsregnskap

Source: The Brønnøysund Register Centre's announcements ↗, read 15 Nov 2026 · All 4 →

Events and registers

§ 15 Charges

Not fetched yet

Events and registers

§ 16 Other registers

Found in 3 of 7

  • The Central Coordinating RegisterRegistered 1 Nov 2021
  • VATRegistered
  • The Register of Business EnterprisesRegistered 1 Nov 2021
  • The Cleaning RegisterNot registered
  • The Register of Staffing AgenciesNot registered
  • Smiley scheme, the Norwegian Food Safety AuthorityNot registered
  • The Financial Supervisory Authority's licence registerNot registered

Purpose: Engros-, postordre- og internettsalg med helsekost/helserelaterte produkter. Import/engroshandel med parfyme og kosmetikk. Engroshandel med spesialisert utvalg av nærings- og nytelsesmidler.

Source: the Brønnøysund Register Centre, the Labour Inspection Authority, the Food Safety Authority and the Financial Supervisory Authority, each on its own, fetched 15 Nov 2026

Market

§ 17 Tenders

None registered

No tenders recorded.No public tenders won, lost or announced, in Doffin or TED. Checked 15 Nov 2026.

Market

§ 18 Vacancies

None registered

No vacancies.No open ads at NAV. Checked 15 Nov 2026.

Market

§ 19 Competitors

Industry code 47.270

The companies most like it:

Compare them

The selection is Intelligo's, not stated by the source: companies met in tenders and winners of tenders of the same kind, otherwise the same industry code, nearest in place and size. Source: the Brønnøysund Register Centre, Doffin and TED, fetched 15 Nov 2026 · All competitors → · Largest in the industry →

Last

§ 20 Questions and answers

6 questions

  • Who owns PROVECTUS PHARMA NORDIC AS?
    1 shareholder. It is PROVECTUS PHARMA INTERNATIONAL AS with 100.0%. § 09
  • What was the revenue in 2025?
    NOK 10.8m in the company. § 06
  • Who can sign for PROVECTUS PHARMA NORDIC AS?
    Styrets medlemmer hver for seg. Styrets leder alene. § 08
  • Who is the auditor?
    SYSTEMREVISJON FOSEN AS, from 17 Aug 2023. § 07
  • Where is PROVECTUS PHARMA NORDIC AS based?
    Slogumveien 99, 2015 Leirsund.
  • When was PROVECTUS PHARMA NORDIC AS founded?
    11 Oct 2021, registered in the Register of Business Enterprises 1 Nov 2021. § 16

The answers come from the sections linked to, with their sources.

01Latest changesOverviewContentsClose